Biomarker & Genomic Testing

CHIP and Cardiovascular Risk: A Meta-AnalysisLung & Thoracic

CHIP and Cardiovascular Risk: A Meta-Analysis


ESMO 2026 meta-analysis of five studies links clonal hematopoiesis to 28% higher lung cancer odds, rising to 48% with large clones and ASXL1 or DNMT3A mutation
Read the Story
Imaging Alone May Spot the High-Risk Mediastinal Lymphoma Patient on Day OneHematologic Malignancies

Imaging Alone May Spot the High-Risk Mediastinal Lymphoma Patient on Day One

Aug 6, 2026 | George Padron
Mapping Parkinson's Genetics Beyond European AncestryPrecision Medicine

Mapping Parkinson's Genetics Beyond European Ancestry

Aug 5, 2026 | George Padron
Barrett's Surveillance Shifts to a Risk-Based FootingGI Cancers

Barrett's Surveillance Shifts to a Risk-Based Footing

Jul 30, 2026 | George Padron

Load More
Only Healthcare Today Covering Clinical Healthcare, Access and Cost

Only Healthcare Today
Covering Clinical Healthcare, Access and Cost

1 Hewitt Square, Suite 139
East Northport, NY 11731

Who We Are


About Us Editorial Policy Contributors & Partners

Connect


Contact Us Work With Us Advertising Terms of Use Privacy Policy